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It has been reported that peel of Punica granatum has antidyslipidemic activity. The aim of this
research was to investigate the antidyslipidemic activity of Punica granatum leaf. The dried
Punica granatum leaves were extracted with 96% ethanol. Rats were divided into several groups,
which were normal, positive control, simvastatin at a dose of 10 mg/kg bw as reference group, and
Punica granatum extract at a dose of 100 mg/kg. Before treatment, male Wistar rats were fed with
high cholesterol chow for 3 months, and then plant extract was given for 4 weeks. Blood samples
were collected at week 0, 12, 14, and 16 to measure the levels of total cholesterol, high-density
lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, and triglyceride.
Furthermore, at the last day of extract treatment, the aorta was isolated and haematoxylin-eosin
stained. Administration of ethanol leaf extract of Punica granatum at a dose of 100 mg/kg for 2 weeks
significantly reduced the total cholesterol and LDL-cholesterol levels up to 27.6% and 34.79%,
respectively, compared to positive control group. After 4 weeks of extract treatment, the reduction
of total cholesterol and LDL-cholesterol level were up to 59.9% and 75.05%, respectively. There
was no effect of extract on HDL-cholesterol and triglyceride level. Furthermore, histological study
showed that ethanol extract of P. granatum reduced aortic wall thickness significantly compared
to untreated group. Punica granatum leaf is potential to be developed as an antidyslipidemic drug.
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INTRODUCTION
Dyslipidemia is a condition of metabolic syndrome
disorder which is characterized by increased levels of
total cholesterol, LDL, triglycerides, apolipoprotein
(apo) B, and decreased levels of HDL. It has been
reported that low HDL levels, high triglycerides, and
cholesterol levels have a significant and independent
relationship to myocardial infarction or stroke (Kolovou
et al., 2005). Therefore, dyslipidemia has become a
risk factor for various cardiovascular diseases such as
atherosclerosis, coronary artery disease, myocardial
infarction, and hypertension.
The prevalence of dyslipidemia is very high in Indonesia.
Based on Indonesian Heart Association (PERKI)
(National Institute of Health Research and Development,
Ministry of Health, Republic of Indonesia, 2013),
Nangroe Aceh, West Sumatra, Bangka Belitung, and
Riau Islands in Indonesia have a prevalence of more than
50%. Furthermore, Indonesia Basic Health Research
(Riskesdas) 2013 data shows that the prevalence of
abnormal cholesterol, HDL, LDL, and triglyceride
levels at age more than 15 years subject in Indonesia
were 35.9%, 22.9%, 60.3%, and 13%, respectively.

Currently, synthetic drugs are used to treat dyslipidemia
if life style modification is not successful. However, high
side effects are still the major problem for synthetic. This
condition has prompted the need for a natural product
that can be used as a dietary supplement to treat or even
prevent the development of dyslipidemia.
Pomegranate (Punica granatum Linn.) has been known
and considered sacred in some countries. Empirically,
the whole part of the pomegranate plant is often used
by communities to treat a variety of diseases. Many
researchers discovered that pomegranate flower extracts
can overcome the condition of hyperglycemia in type
II diabetes and obesity (Li et al., 2005; Huang et al.,
2005; Jafri et al., 2000; Bhaskar &Kumar, 2012).
Concentrated pomegranate fruit juice can improve
lipid profiles in diabetic patients with hyperlipidemia
(Esmaillzadeh et al., 2004). In addition, pomegranate
fruit juice may slow the oxidation of cholesterol by up
to half, and lowered the LDL level (Abaas et al., 2014).
Furthermore, pomegranate leaves have been reported
to have antihyperglycemic and antihyperlipidemic
activity in streptozotocin-induced diabetic rats (Patel
et al., 2014). However, the antihyperlipidemic activity
of pomegranate leaves has not been fully explored
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using dyslipidemic rat model. Therefore, in this study,
antidyslipidemia of pomegranate leaves will be studied
using dyslipidemic rat model.
METHODS
Materials
The following materials were used in this study: highcholesterol chow 10 kg (20 pieces of chicken liver, 1
kg of cow fat, 1 kg of goat fat, 75 quail eggs, 20 duck
eggs, 3 kg of wheat flour and 2 kg of corn flour), normal
chow, cholic acid, pure cholesterol, propylthiouracil
(PTU), vegetable oil, aquadest, NaCl 0.9% solution and
CMC-sodium. The chemicals used were ethanol, xylol,
formaldehyde, paraffin wax, haematoxylin, and eosin
(Merck, Germany). Total cholesterol kit, HDL kit, and
triglyceride kit was supplied by PT. Rajawali Nusindo,
Jakarta, Indonesia.
Test Animals
The test animals were 20 male Wistar rats aged 10–12
weeks and weighing 200–350 g. The animals were
obtained from the Animal Laboratory of School of
Pharmacy, Bandung Institute of Technology. All
animal experimental protocols have been approved
by the Institutional Animal Ethics Committee (IAEC)
in accordance with the Committee’s guidelines for
the Objective of Supervision and Control of Animal
Experiments (No. 05/KEPHP-ITB/2016).
The test animals were placed in cages under suitable
environments based on animal testing standards. There
were four groups consisting of five rats each. Group
one was the normal group that was fed with normal
chow, without any extract treatment. While group
two (positive control group), three and four were fed
with high cholesterol chow for 12 weeks to develop
dyslipidemic rats. Moreover, for group three consisted
of dyslipidemic rats that were treated with simvastatin as
a reference drug. Furthermore, group four were treated
with P. granatum leaf extract at dose of 100 mg/kg bw.
Antidyslipidemic Rat Model
Dyslipidemia was induced in the animals through the
oral administration of a high-cholesterol diet and water
ad libitum, as well as PTU, pure cholesterol, and cholic
acid. PTU 12.5 mg/kg bw/day was suspended in 0.3%
CMC-Na with aquadest as the solvent. Cholic acid 200
mg/kg bw/day and pure cholesterol 100 mg/kg bw/day
were dissolved in vegetable oil. PTU, cholic acid and
pure cholesterol were administered orally to the rats for
5 consecutive days each week. The high-cholesterol feed
composition was prepared from 20 pieces of chicken
livers, 1 kg of cow fat, 1 kg of goat fat, 75 quail eggs,
20 duck eggs, 3 kg of wheat flour, and 2 kg of corn
flour. Cholesterol-rich feed was administered daily for
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12 weeks. Afterward, simvastatin and P. granatum leaf
extract were given daily for 4 weeks (Nurfatwa, 2016).
Collection of Rat Blood
Rat blood was collected for the evaluation of lipid
profile. Rats were put inside restriner and then blood
was collected through lateral venous blood vessels in
the rat tails. A total of 0.3 mL of blood was collected
into Eppendorf tubes and centrifuged for 5 min at 10,000
rpm. After centrifugation, the serum was collected
and stored at −20 °C. Lipid profile analysis included
the measurement of total cholesterol, triglycerides,
High-density lipoprotein (HDL)-cholesterol, and Lowdensity lipoprotein (LDL)-cholesterol (Safitri, 2016).
Total cholesterol of serum collected at before induction,
12 weeks after induction, and every 2 weeks during
treatment were measured. While for the other lipid
profiles, measurements were done for serum collected at
week 2 and 4 of simvastatin or extract treatment.
Quantification of Lipid Markers
Commercially available kits were used to measure
the levels of total cholesterol, triglycerides, and HDL
according to the manufacturer’s instructions. All kits
were purchased from PT. Rajawali Nusindo, Jakarta,
Indonesia. While for LDL cholesterol, the level was
determined using the Friedewald equation as follows
(Sukandar, 2016):
LDL = Total Cholesterol − HDL − (Triglyceride/5)
Aorta Histology
The test animals were sacrificed using CO2, then
heart and aorta of rats were dissected and isolated for
histology. The aorta was soaked in buffered formalin
for 1 week. The aorta then was immersed in a container
which contains 70% ethanol, 80% ethanol, 90% ethanol,
95% ethanol, and absolute ethanol respectively for 4
hours. Furthermore, the aorta was immersed in xylol in
3 different containers each for 1 hour to remove residual
alcohol from the aorta. Paraffin in solid form was further
heated at temperature of 60-65ºC until liquid and the
aorta then was blocked with paraffin. Next, paraffinized
aorta was sliced using a microtome with a thickness of 3
μm and placed on the object glass.
Haematoxylin-Eosin Staining
The object glass that has been filled with pieces of the
aorta was put into containers containing xylol, absolute
ethanol, 95% ethanol, 90% ethanol, 80% ethanol, and
70% ethanol for 2 minutes to remove paraffin. The
object glass was then washed with clean water to remove
alcohol and put in a container filled with hematoxylin
dye for 15 minutes. Furthermore, it washed again to
remove any residual haematoxylin and put into the
container which contains eosin dye for 2 minutes. Then,
E-ISSN 2477-0612
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Figure 1. Effect of extract on cholesterol level of dyslipidemic rats.
All values are expressed as Mean±SD, n=5; #p<0.05 compared
to normal; *p<0.05 compared to positive control. The statistical
calculation was performed using Anova.

Figure 2. Effect of extract on triglyceride level of dyslipidemic rats.
All values are expressed as Mean±SD, n=5; #p<0.05 compared
to normal; *p<0.05 compared to positive control. The statistical
calculation was performed using Anova.
it was put into 70% alcohol, alcohol 80%, 90% alcohol,
95% alcohol, absolute alcohol, and xylol for 2 minutes
each. The object glass cleaned for the remaining xylol
and covered with a cover glass. Furthermore, the slide
was observed under a microscope.
Statistical Analysis
ANOVA in SPSS 21.0 was used to analyze statistically
significant differences between the control and the
experimental groups. p < 0.05 was considered to be
statistically significant.
E-ISSN 2477-0612

RESULTS AND DISCUSSION
At the beginning of induction of dyslipidemia, the
average total cholesterol level of all the test groups was
78.4 mg/dL which were not statistical different among
other groups (Figure 1). After 12 weeks of induction, the
total cholesterol level of the dyslipidemic rats increased
significantly compared to normal group (Figure 1). P.
granatum leaf extract at dose of 100 mg/kg bw given
for a month on dyslipidemic rat could reduce total
cholesterol and LDL-cholesterol level. Unpublished
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data showed that an increase dose of the extract could
increase its activity in reducing total cholesterol and
LDL-cholesterol level.
In this study, the induction of dyslipidemia was
performed exogenously for 3 months. The chow
compositions for dyslipidemia induction were high
cholesterol chow, 100 mg/kg bw pure cholesterol in
vegetable oil, 200 mg/kg bw of cholic acid in vegetable
oil, and propylthiouracil 12.5 mg/kg bw in aquadest.
Cholic acid is one of the major bile acids in the body

Pharm Sci Res, Vol 8 No 2, 2021

89

that was given to increase the absorption of exogenous
cholesterol by inhibiting cholesterol conversion to bile
acids (Hall, 2016). Meanwhile, propylthiouracil was
given to inhibit metabolism of cholesterol, therefore it
increased the levels of cholesterol serum (Rizos et al.,
2011). In this study, we only used male rats as it has been
shown in previous publication that there is no effect of
gender in increasing of serum and hepatic cholesterol
level upon cholesterol supplementation (Marounek et al.,
2012).

Figure 3. Effect of extract on HDL-cholesterol level of dyslipidemic
rats. All values are expressed as Mean±SD, n=5; #p<0.05
compared to normal; *p<0.05 compared to positive control. The
statistical calculation was performed using Anova.

Figure 4. Effect of extract on LDL-cholesterol level of dyslipidemic
rats. All values are expressed as Mean±SD, n=5; #p<0.05
compared to normal; *p<0.05 compared to positive control. The
statistical calculation was performed using Anova.
E-ISSN 2477-0612
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Upon simvastatin treatment, it was found that
simvastatin could reduce total cholesterol and LDL
level significantly compared to positive control (Figure
1 and 4). Furthermore, it could increase HDL level
significantly but had no effect on triglyceride level
(Figure 2 and 3). Simillar to simvastatin, punica leaf
extract treatment could reduce total cholesterol and LDL
levels significantly compared to positive control after 2
and 4 weeks of treatment (Figure 1 and 4). However, it
has no effect on triglyceride and HDL levels at any time
of observation (Figure 2 and 3).

leaf has antidyslipidemia effect, however the animal model
used was alloxan or streptozotocin-induced non–insulindependent diabetes mellitus albino rats (Das & Barman,
2012; Salwe et al., 2015). Alloxan and streptozotocin are
known as a substance that can damage ß-cell pancreas,
leading to hyperglycemia. Although diabetic rats exhibit
abnormalities in lipid metabolism as evidenced by the
elevated levels of cholesterol, triglycerides, low-density
lipoprotein cholesterol and very low-density lipoprotein,
this model is not directly showed its effect on induction
of dyslipidemia exogenously.

Histological study showed that high cholesterol
induction exhibited a significant increased aortic wall
thickness compared to normal group. In simvastatin
and P. granatum leaf extract group, the treatments could
reduce aortic wall thickness significantly compared to
positive control (Figure 5).

Besides the leaf, the antihyperlipidemia activity of the
flower, fruit (aril and seed), and fruit peel of Punica
granatum has also been studied (Abaas et al., 2014;
Sadeghipour et al., 2014). All those parts of Punica
granatum showed its activity in lowering the lipid
profile. Compared to aril and seed, fruit peel of Punica
granatum had better effect on lowering total cholesterol
level (Mageid et al., 2016). It would be interesting to
study further on its activity compared to leaf extract.

The results of this study suggest that Punica granatum leaf
extract has potential to be developed as antidyslipidemia
drug. It has been reported before that Punica granatum

Figure 5. Histological examination of aortic hypertrophy in extract treated
dyslipidemic rats. (A) Representative cross section of aortic wall stained with
HE. Magnification 400x. (B) Bar graphs show the quantitative analysis of aortic
wall thickness. N=3, *P<0.05 vs positive control. The statistical calculation was
performed using Anova.
E-ISSN 2477-0612

The Effect of Ethanol Extract of Punica granatum Linn. Leaves

Punica granatum fruits, seeds, and peels contain
numerous valuable ingredients such as flavonoids,
ellagitannin, punicalagin, ellagic acid, vitamins,
and minerals (Jasuja et al., 2012). Punicalagins and
ellagitannin have been reported to be responsible
for immeasurable health benefits due to its strong
antioxidant activity (Suo et al., 2009). Antioxidant has
been reported to play a role in protecting from oxidative
damage by reactive oxygen species, thus it might reduce
the peroxidation rate and prevent the progressive disease
due to dyslipidemic condition (Yang et al., 2008). Recent
evidences showed that Punica granatum fruits, peels,
and seeds can inhibit free radical effect and modulation
of enzymes activity linked with diseases development
and progression (Rahmani et al., 2017). P. granatum
leaves contains tannins (punicalin and punicalagin),
flavonoid glycosides (luteolin and apigenin) (Jurenka,
2008). Tannins are able to decrease cholesterol and
triglyceride serum level in high-fat diet-induced obese
mice (Lei et al., 2007). For futher research, it would be
interesting to find the major component that play a role
in antidyslipidemia effect.
CONCLUSION
This study demonstrated that pomegranate leaf extract at
dose of 100 mg/kg bw rat has potential to be developed
as antidyslipidemia drug as it can reduce total cholesterol
and LDL-cholesterol level in hypercholesterolemia
chow-induced dyslipidemic rat model.
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